Related Experiment Video

Updated: Aug 19, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

[Methods of directly influencing the metastatic process]

K P Balitskiĭ

    Voprosy Onkologii
    |January 1, 1984
    PubMed

    Insights

    Interferon prevents cancer metastasis by activating immune cells. Neuro-regulatory mechanisms and target-organ vascular injury, influenced by stress hormones, also impact tumor spread.

    Area of Science:

    • Oncology
    • Immunology
    • Neuroendocrinology

    Context:

    • Tumor dissemination and metastasis are critical challenges in cancer treatment.
    • Understanding the interplay between the immune system, neuroendocrine factors, and cancer progression is essential.

    Purpose:

    • To investigate the mechanisms by which agents modify tumor dissemination.
    • To elucidate the role of interferon in preventing metastatic spread.
    • To establish the relationship between tumor dissemination and neuro-regulatory mechanisms.

    Summary:

    • Experimental studies explored agents affecting tumor dissemination.
    • Interferon demonstrated a preventive effect on metastatic spreading, attributed to the activation of non-specific immune surveillance effector cells.
    • A link was found between tumor dissemination and the neuro-regulatory status of target organs.

    Impact:

    • Findings suggest interferon's therapeutic potential in inhibiting cancer metastasis via immune activation.
    • Highlights the influence of neuroendocrine pathways and target-organ vascular integrity on metastatic processes.
    • Provides insights into modulating host-response mechanisms to control cancer spread.

    More Related Videos

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior09:44

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

    Published on: June 13, 2016

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Related Concept Videos

    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...